|Median Technologies SA -- France Stock|| |
EUR 10.1 0.35 3.35%
Ms. Jeanne Hecht serves as Chief Operating Officer of the Company. As Chief Operating Officer, Jeanne Hecht is responsible for leading, implementing and driving the company global strategy. Jeanne Hecht has more than 20 years of experience in the healthcare industry and is also a certified Project Management Professional . She is expected to join MEDIAN Board of Directors at the next General Shareholder Meeting on 16 December 2016. Jeanne was previously at Quintiles, the industry leading Contract Research Organization where she served in a variety of capacities. Most recently she was Senior Vice President of Site Patient Networks. In 2012, Jeanne partnered with MEDIAN Technologies when she was Global Head of Sales at Quintiles. Earlier in her career, Jeanne was a founding member of a company utilizing biomarkers for companion diagnostic purposes. Jeanne earned her MBA and bachelor degree in Science from the University of Michigan.
COO Since 2016 MBA
33 4 93 33 37 77 http://www.mediantechnologies.com
The company has return on total asset (ROA)
of (14.44) %
which means that it has lost $14.44 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (28.04) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 459 K in total debt with debt to equity ratio (D/E) of 1.1 which is about average as compared to similar companies. Median Technologies SA has Current Ratio of 7.63 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
MEDIAN Technologies S.A. offer medical imaging solutions and services for diagnosing and monitoring cancer patients in routine clinical practice and clinical drug development. Median Technologies SA (ALMDT) is traded on Paris Stock Exchange in France. It is located in Valbonne, and employs 87 people.